Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVicore Pharma Ho Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q2 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q3 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2026 | 1 | -$0.53 | -$0.53 | -$0.53 |
| Q1 2027 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q2 2027 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q3 2027 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q4 2027 | 1 | -$0.46 | -$0.46 | -$0.46 |
Vicore Pharma Ho Earnings Date And Information
Vicore Pharma Ho last posted its earnings results on Friday, August 21st, 2026. The company reported $-0.51464 earnings per share for the quarter, missing analysts' consensus estimates of $-0.42158 by $0.09306. The company had revenue of 228.25 K for the quarter and had revenue of 3.82 M for the year. Vicore Pharma Ho has generated $-2 earnings per share over the last year ($-2.2 diluted earnings per share) and currently has a price-to-earnings ratio of -5.13. Vicore Pharma Ho has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Vicore Pharma Ho Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/21/2026 | Q2 2026 | -$0.42 | -$0.53 | -0.11 | $226.61 K | $228.25 K |
| 03/31/2026 | Q1 2026 | N/A | -$0.41 | N/A | $51.06 K | $602.00 K |
| 12/31/2025 | Q4 2025 | N/A | -$0.58 | N/A | $86.17 K | $419.00 K |
| 09/30/2025 | Q3 2025 | N/A | -$0.51 | N/A | N/A | $80.73 K |
| 06/30/2025 | Q2 2025 | N/A | -$0.52 | N/A | N/A | $1.75 M |
| 03/31/2025 | Q1 2025 | N/A | -$0.47 | N/A | $78.78 K | $892.00 K |
| 12/31/2024 | Q4 2024 | N/A | -$0.35 | N/A | N/A | $461.23 K |
| 09/30/2024 | Q3 2024 | N/A | -$0.53 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.48 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | $0.27 | N/A | N/A | $9.76 M |
| 12/31/2023 | Q4 2023 | N/A | -$0.99 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.53 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.78 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.78 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | -$0.79 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$0.86 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.90 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$1.40 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$1.20 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$1.60 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vicore Pharma Ho Earnings: FAQ's
The conference call for Vicore Pharma Ho's latest earnings report can be listened to online.
The conference call transcript for Vicore Pharma Ho's latest earnings report can be read online.
Vicore Pharma Ho (:VCRE) has a recorded annual revenue of $3.82 M.
Vicore Pharma Ho (:VCRE) has a recorded net income of $-477,474,000.Vicore Pharma Ho has generated $-2.2 earnings per share over the last four quarters.
Vicore Pharma Ho (:VCRE) has a price-to-earnings ratio of -5.13 and price/earnings-to-growth ratio is -0.31.